High RBM3 expression was significantly associated with favorable clinicopathological characteristics, including a low FIGO stage, absence of distant metastasis, and a favorable histologic subtype in epithelial ovarian cancer. The gene discussed is RBM3; the disease is ovarian carcinoma.